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Assessing Consensus Between UK Renal
Clinicians on Listing for Kidney Transplantation:
A Modified Delphi Study
Sarah Tonkin-Crine, PhD,1 Rishi Pruthi, MBBS,2 Dominic M. Taylor, MbCHb,2,3 Geraldine M. Leydon, PhD,2
Melania Calestani, PhD,4 Gabriel C. Oniscu, MD,5 J. Andrew Bradley, PhD,6 Charles R. Tomson, DM,7
Clare Bradley, PhD,8 Christopher Dudley, MD,3 Christopher J.E. Watson, MD,6 Heather Draper, PhD,9
Rachel J. Johnson, MSc,10 Wendy Metcalfe, MD,11 Damian G. Fogarty, MD,12 Rommel Ravanan, MD,3
and Paul Roderick, MD,2 on behalf of ATTOM Investigators
Background. It is well recognized that there is significant variation between centers in access to kidney transplantation. In the
absence of high-grade evidence, it is unclear whether variation is due to patient casemix, other center factors, or individual clinician
decisions. This study sought consensus between UK clinicians on factors that should influence access to kidney transplantation.
Methods. As part of the Access to Transplantation and Transplant Outcome Measures project, consultant nephrologists and
transplant surgeons in 71 centers were invited to participate in a Delphi study involving 2 rounds. During rounds 1 and 2, partic-
ipants rated their agreement to 29 statements covering 8 topics regarding kidney transplantation. A stakeholdermeetingwas used
to discuss statements of interest after the 2 rounds.Results. In total, 122 nephrologists and 16 transplant surgeons from 45 units
participated in rounds 1 and 2. After 2 rounds, 12 of 29 statements reached consensus. Fifty people participated in the stakeholder
meeting. After the stakeholder meeting, a further 4 statements reached agreement. Of the 8 topics covered, consensus was
reached in 6: use of a transplant protocol, patient age, body mass index, patient compliance with treatment, cardiac workup,
and use of multidisciplinary meetings. Consensus was not reached on screening for malignancy and use of peripheral Doppler
studies. Conclusions. The Delphi process identified factors upon which clinicians agreed and areas where consensus could
not be achieved. The findings should inform national guidelines to support decisionmaking in the absence of high quality evidence
and to guide areas that warrant future research.
(Transplantation Direct 2018;4:e343; doi: 10.1097/TXD.0000000000000782. Published online 17 April, 2018.)
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K idney transplantation is widely considered to be the op-timum treatment for many patients with established re-
nal failure. However, the number of patients requiring a
kidney transplant far exceeds the number of available or-
gans.1 In this context, it is important that clinicians make
evidence-based decisions regarding benefits of transplanta-
tion, when deciding which patients should be assessed for
transplantation and which should join the waiting list.2 The
decision to waitlist patients for transplantation is influenced
by many clinical factors and much work has gone into pro-
ducing guidelines to ensure patients have access to available
treatment options.3 In the absence of high-grade evidence to
support or discourage transplantation in specific patient
groups, many of the recommendations draw on “expert
opinion.” It is possible that the lack of a strong evidence-
based produces variation in practice between individual clini-
cians, which in turn contributes to variation between renal
units in terms of listing policy for kidney transplantation.4
Although several factors have been identified which influence
clinicians' decisionmaking,5 it is unclear whether there is ma-
jority consensus between clinicians on many aspects of the
transplant preparation process.
A survey of clinical practice across UK transplant centers
confirmed variations in practice and identified areas where
there is disagreement, such as the assessment of cardiovascu-
lar comorbidity, body mass index (BMI) and age.6 This study
informed a large UK wide research program, Access to
Transplant and Transplant Outcome Measures (ATTOM).
One of the aims of ATTOM is to investigate how to improve
equity of access to kidney transplantation across the United
Kingdom by systematically assessing patient- and center-
specific factors influencing access to transplantation. Access
to Transplant and Transplant Outcome Measures involved 5
workstreams,7 one of which encompassed the 5 studies shown
in Figure 1,8 including the current Delphi consensus process.
All studies investigated factors which may influence clinicians'
decisions to list patients for kidney transplantation.
The current study aimed to use a Delphi approach to seek
consensus between individual clinicians on factors they
deemed important when making a decision whether or not
to list a patient for kidney transplantation.
MATERIALS AND METHODS
Design and Setting
The study followed a modified Delphi process with clini-
cians from renal units in the United Kingdom. The Delphi ap-
proach is a formal consensus method recommended by the
National Institute for Health and Care Excellence for enhanc-
ing effective decision making in healthcare.9 The approach
aims to enhance collective decisionmaking by keeping individ-
uals' responses anonymous from one another and reducing
the effect of dominant individuals on the group decision.10
There are several types of Delphi method which vary in their
design;11 a modified Delphi method using questionnaires
was chosen for this study. The method was modified as
the research team started with a set of preselected items
to form the basis of the first questionnaire round. Two
questionnaire rounds were performed. Anticipating that
some questions would not reach consensus within 2 rounds,
a further opportunity to reach consensus was provided in the
form of a stakeholder meeting. The ATTOM study received
ethical approval from Cambridgeshire Central Research Ethics
Committee (ref: 11/EE/0120).
Participants
Consultant nephrologists and consultant transplant sur-
geons from all 71 UK renal units (23 transplanting and 48
nontransplanting units) were invited by email to participate
in the study. Consultant grade clinicians were invited to take
part as they represent staff who take overall responsibility for
decisions about whether patients are listed for kidney trans-
plantation. It was not possible to identify every practicing ne-
phrologist in the United Kingdom along with reliable contact
details, so in an attempt to recruit as many consultant ne-
phrologists as possible, email invitations were sent to clini-
cal directors at each unit, with a request for them to forward
details to their consultant colleagues. Clinicians were consid-
ered to have given informed consent to participate if they re-
sponded to the invitation.
Questionnaire Items
The development of the initial Delphi questionnaire was
informed by the results of a survey of all UK renal units,
which aimed to identify variation in practice patterns in the
process ofwaitlisting for kidney transplantation.12 This survey
found significant variation in the reported age limit for trans-
plantation, the reported BMI cutoff, the investigations deemed
necessary during transplant workup and the indications for
such investigations. From 71 centers, 30% did not use a writ-
ten transplant protocol, and 24%did not usemultidisciplinary
team (MDT) approach for transplant decision making.
One additional item identified from a related qualitative
study (Pruthi R, personal communication) exploring individual
FIGURE 1. Adiagram showing the 5 studies carried out within ATTOM
workstream 1.
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clinician views about listing was also added. Free-text com-
ments were also allowed in the survey to allow participants to
explain the reasons for their responses.
Twenty-nine items were identified for round 1 of the Delphi
process, representing 8 broad themes (need for a written
protocol, recipient age, recipient BMI, cardiac assessment,
peripheral vascular disease, malignancy, compliance, need for
MDT). Statements were drafted by the research team with ex-
pert advice from consultant nephrologists and transplant sur-
geons to ensure that they were clear and comprehensible.
Statements were formatted into an online questionnaire using
the software SurveyMonkey (http://www.surveymonkey.com)
(see Supplemental Digital Content, http://links.lww.com/
TXD/A79).
Procedure and Analysis
Round 1
Potential participants received an email with a web link to
round 1 of the Delphi along with information about the aim
of the study and eligibility criteria. Participants were asked to
indicate their level of agreement with each statement by using
a 9-point Likert scale (1, strongly disagree; 9, strongly agree).
Free-text boxes were provided for any participant comments.
Participants were given 6 weeks to respond. The median and
interquartile range (IQR) for each statement were calculated
using Microsoft Excel 2010. Group consensus agreement
was defined a priori as a median group rating of 8 or more
of 9. Median and IQR were used as measures of consensus
because they are less susceptible to influence by outlying
responses. Items achieving consensus agreement in round
1 were accepted. Items not achieving consensus agreement
were circulated back to the participants for reconsidera-
tion in Round 2.
Round 2
Only participantswho completed all statements in round 1
were invited to take part in round 2. Participants were sent a
personalised email with a web link to the round 2 question-
naire. An attachment gave participants the results of round
1 with the average group score for each statement along with
the participant’s original response. Participants could give
the same answers to Round 2 as given in Round 1, or could
TABLE 1.
Results from the Delphi process
Delphi rounds 1 and 2 responses; 0-9 (0, strongly disagree; 9, strongly agree)
Median score (IQR)
Round 1 Round 2
1 A written transplant work-up protocol is needed for assessment of patients to be listed for kidney transplantation 8 (7-9) —
2 There should be an upper age limit of 80 years for listing for transplantation 5 (2-8) 5 (2-7)
3 There should be an upper age limit of 75 years for listing for transplantation 4 (2-7) 4 (2-6)
4 There should be an upper age limit of 70 years for listing for transplantation 2 (1-4) 2 (1-3)
5 There should be a maximum BMI exclusion criterion of 40 kg/m2 6 (2-8) 6 (3-8)
6 There should be a maximum BMI exclusion criterion of 35 kg/m2 5 (3-8) 4 (2-7)
7 There should be a maximum BMI exclusion criterion of 30 kg/m2 2 (1-3) 2 (1-2)
8 There should be a minimum BMI exclusion criterion of 20 kg/m2 2 (2-5) 2 (2-4)
9 There should be a minimum BMI exclusion criterion of 18 kg/m2 5 (2-6) 4 (2-6)
10 The minimum cardiac work-up undertaken for patients being assessed for transplant listing should include at least an ECG and ECHO 7 (5-8) 7 (5-8)
11 The minimum cardiac work-up undertaken for patients being assessed for transplant listing should include a stress test 3 (2-4.75) 2 (2-5)
12 Cardiac assessment for patients undergoing listing for transplantation should be stratified by risk 8 (8-9) —
13 Asymptomatic CAD identified on pretransplant workup should be revascularized before listing for transplantation 5 (3-7) 5 (3-6)
In the evaluation of lower limb peripheral vascular disease, Doppler studies should be done for:
14 Asymptomatic older patients 5 (2-7) 5 (2.75-7)
15 All patients with diabetes 7 (4-8) 7 (5-8)
16 Symptomatic patients 9 (8-9) —
17 Asymptomatic patients with poor peripheral pulses 8 (7-9) —
18 Patients with asymptomatic bruit 8 (5.25-8) —
19 History of smoking 6 (4-8) 6.5 (4-8)
Patients should be routinely screened for malignancies as part of transplant assessment workup. All patients should be screened for:
20 Prostate (men) 7 (5-8) 6 (3.5-8)
21 Breast (women) 8 (6-8)a 6 (4-8)
22 Cervical (women) 8 (7-8)a 7 (4-8)
23 Skin 7 (5-8) —b
24 Colorectal 5 (3.25-8) 5 (3-7)
25 Bladder 5 (3-7.75) —b
26 Lung 6 (4-8) —b
27 Poor compliance (taking medication and/or clinic attendance) should be a factor which influences listing for transplantation 8 (7-8) —
28 An MDT approach is needed when discussing all patients for listing for transplantation 7 (4-8) 8 (6-9)
29 An MDT approach is needed when discussing complex/borderline patients for listing for transplantation 9 (8-9) —
Shading indicates consensus agreement; shading of scores indicate the round in which consensus was reached. Underlining indicates consensus disagreement after round 2.
a Two results from round 1 were not considered to have reached consensus agreement because clinicians written responses indicated misinterpretation of the statements—these were reworded for round 2.
b Three questions were not included in round 2 because they were felt to be too complex.
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change their earlier answers, and were given 5 weeks to re-
spond. Up to 3 reminders were sent to nonresponders. Again,
group consensus agreement was defined as a median score of
8 ormore of 9. Consensus disagreement was defined as a me-
dian score of 2 or fewer of 9.
Stakeholder Meeting
Results from rounds 1 and 2 were presented to the attendees
of the National Health Service Blood and Transplant Renal
Transplant Services annual meeting in March 2015. Renal
Transplant Services is a national forum representing all units
providing renal transplantation services in the United Kingdom,
as well as other transplant stakeholders (eg, histocompatibil-
ity laboratories, commissioners and patients). The group was
asked to vote on 3 statements that had not reached consensus
in the previous rounds to see whether discussion helped to
achieve consensus. The 3 statements were those that had
greatest variation based on the IQR of responses in Rounds 1
and 2 (Table 1). Participants were asked to vote anonymously
for 1 option using electronic voting pads. Open discussion
was recorded by field notes made by members of the research
team. Three other members of the team (R.P., R.R., and G.O.)
coordinated discussions and presented data to the group.
RESULTS
Participation in rounds 1 and 2 is shown in Figure 2. A to-
tal of 167 participants from 49 renal units responded to
round 1, which represents about a quarter of the nephrolo-
gists and surgeons and two thirds of the renal units in the
United Kingdom (Table 2).11 The number of clinicians
responding in each unit varied from 1 to 13 (median, 2).
The recruitment method did not allow enumeration of the
number of clinicians who received an invitation to participate
in the study.
Figure 3 summarizes the outcomes of rounds 1 and 2.
Round 1
Seven (24%) of the 29 statements obtained consensus
agreement in round 1 (Table 1 and Figure 3). These included
agreement between participants over 3 broad themes: (1) that
written protocols should be used for assessment of patients
for transplantation, (2) that cardiac assessment should be
stratified by risk, and (3) that poor compliance with treatment
should be a factor taken into consideration when assessing
patients for waitlisting. Many participants provided free-text
comments, especially regarding patient age and BMI. Many
FIGURE 2. A flowchart showing responses to the Delphi in rounds 1
and 2.
TABLE 2.
Clinical speciality of participants who responded to round 1
and characteristics of the renal units in which they worked
Individual clinicians No. responses (%)
Clinical specialty
Nephrology 136/550a (25)
Surgery 24/150a (16)
Renal unit representation No. responses (%)
Of all UK renal units 49/71 (69)
By UK region
England 36/53 (68)
Wales 2/4 (50)
Scotland 9/9 (100)
Northern Ireland 2/5 (40)
By type of unit:
Transplanting 19/23 (83)
Nontransplanting 30/48 (63)
a Total consultants in Nephrology (550) and Transplant Surgery (150). Data from workforce survey by
the Royal College of Physicians.12
FIGURE 3. A flowchart showing the results of rounds 1 and 2.
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felt BMI was an unhelpful measure and were reluctant to
make decisions about listing based on BMI alone. Several
emphasized that listing decisions were based on individuals
patient circumstances and that cutoff values for age or BMI
would not apply to everyone and such single-variable values
were, therefore, unhelpful.
The statement concerning screening for malignancies in
round 1 was perceived as lacking in clarity, and it was
amended for round 2. Three items, relating to specific malig-
nancies (skin, bladder, and lung) were removed from round 2
as they were felt to be too complex. Two statements regard-
ing malignancy had reached consensus, but the free text com-
ments indicated that some hadmisinterpreted the statements.
These were amended and included in round 2. No new topics
of interest were identified.
Round 2
In round 2, 157 clinicians who rated all statements in
round 1were invited to take part and 135 completed all state-
ments (Figure 2); the response rate for nephrologists was
91% and for surgeons, 73%. Respondents came from 45
(63%) renal units; representing 17 (71%) transplant
units and 28 (58%) nontransplant units. Between 1 and 13
(median, 2) responses were received for each unit.
One statement in round 2 reached consensus agreement
(Table 1 and Figure 3). Participants agreed that MDT meetings
were useful for all patients being considered for listing for
transplantation, rather than for complex patients only. In
addition, 4 statements reached consensus disagreement with
scores of 2 or fewer. For the remaining statements, scores
appeared to change in the direction of consensus (agreement
or disagreement), indicating that participants had been
influenced by the group score. However, wide variation
remained in all responses (Table 2).
Nineteen participants did not respond in round 2, and 3
were not invited to take part in round 2 because they did
not fully complete round 1 (Figure 2). This meant that the 2
groups in each round were not the same. To account for this
difference, results were reanalyzed, removing data contributed
by these 22 participants from round 1 (Table S1, http://
links.lww.com/TXD/A79). This made no difference to the
consensus decisions indicated by the process.
Fewer free-text comments were provided in Round 2. No
participants reported having problems with understanding
the questionnaire. Participants shared similar views toRound
1, providing comments regarding BMI and age and the need
to assess patients on an individual basis.
Stakeholder Meeting
An attendance list was collected for the stakeholder meet-
ing. Seventy people attended the meeting with 15 transplant
surgeons and 16 nephrologists present, and of these, 13 (42%)
had taken part in the previous 2 rounds. The remainder of
the audience consisted of other professionals including histo-
compatibility laboratory leads, researchers and statisticians,
and 8 patient representatives. All attendees were invited to
vote on 3 statements concerning BMI, age, and asymptom-
atic coronary artery disease (CAD) revascularization.
The results indicated similar variability in opinion as for
the previous rounds (Table 3). Between 24 and 50 participants
voted for each question, indicating that not all responses
were from clinicians.
Participants voted for a BMI cutoff of 35 or 40 kg/m2, and
most votes were evenly divided between these options
(Table 3). In discussion, some surgeons highlighted
examples of cases where they would undertake transplantation
on patients with a BMI over 40 kg/m2 (such as in younger
recipients). Others felt that BMI was not a useful measure
to assess risk of transplantation. Several highlighted that
assessment for transplantation required a holistic process
rather than consideration of separate clinical factors. Overall,
attendees felt that it was appropriate to undertake
transplantation in patients with a BMI of up to 40 kg/m2.
Most attendees (61%) voted for an upper age cutoff of
80 years (Table 3) although in discussion, many felt that it
was inappropriate to have a specified age limit because
there were always exceptional cases. Some specifically
mentioned that a patient’s biological age rather than
chronological age should be considered. However, with
a limited supply of organs, attendees suggested that there
was a need to maximize a kidney transplants life expectancy
and this ultimately disadvantages older patients, who may
be predicted to die more often with a functioning kidney
transplant. Attendees agreed that an age limit of 80 years
was most appropriate out of the choices provided, although
it was felt that age alone was not useful as a factor to
influence decision making.
Lastly, participants' views were split over whether patients
with asymptomatic CAD should undergo cardiac revascular-
ization (Table 3). In the final group discussion, transplant
surgeons appeared more likely to agree with this statement
than nephrologists. Some perceived a trend toward lower
rates of revascularization, driven by cardiologists, such that
nephrologists now have an increased influence on this process.
Some suggested that a randomized controlled trial would
be helpful in assessing the need for revascularization. No
consensus was reached on this statement.
Overall, the discussion led to agreement on 2 of the 3
statements presented to the audience (Table 3). This equated
to consensus agreement for 2 of the statements presented in
rounds 1 and 2 (BMI cutoff 40 kg/m2 and age cutoff
80 years) and consensus disagreement for 2 other statements
(BMI cutoff should not be 30 kg/m2 and age cutoff should
not be 70 years).
TABLE 3.
Responses in the round 3 stakeholder meeting for 3 of the
statements that did not reach consensus in round 2
Statements Options n (%)
(1) The maximum BMI exclusion criterion for listing for
transplantation for most patients should be:
BMI 30 kg/m2 3 (6)
BMI 35 kg/m2 24 (48)
BMI 40 kg/m2 23 (46)
Total vote 50 (100)
(2) The upper age limit for listing for transplantation for
most patients should be:
80 years 27 (61)
75 years 16 (36)
70 years 1 (2)
Total vote 44 (100)
(3) Asymptomatic CAD identified on pretransplant workup
should be revascularized before listing for transplantation.
Agree 10 (42)
Disagree 9 (38)
Neither 5 (21)
Total vote 24 (100)
Shading indicates consensus agreement; Underlining indicates consensus disagreement; No consen-
sus was reached for question 3.
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DISCUSSION
To our knowledge, this is the first study using a consensus
approach to elicit the views of senior transplant clinicians on
the factors influencing listing for kidney transplantation.
Using a modified Delphi approach, clinicians were invited
to take part in 2 rounds, via a web questionnaire, and results
were presented at a stakeholder meeting. Clinicians reached
consensus on several of the statements included in the Delphi
rounds. They agreed that a written transplant workup proto-
col should be followed and that cardiac assessment should be
stratified by risk. There was agreement that peripheral vascu-
lar Doppler ultrasound studies were useful for symptomatic
patients with poor peripheral pulses and patients with an
asymptomatic arterial bruit. Clinicians felt that patient com-
pliance with treatment should be considered when making a
decision to list and that anMDTapproach to the listing deci-
sion should be used for all and not just for complex patients.
Clinicians did not support BMI cutoffs of over 30 kg/m2,
over 35 kg/m2, or under 20 kg/m2. They were also against
an age limit of 70 or 75 years, acknowledging that age must
not be used as a proxy for the proper assessment of individual
need and suitability for transplantation. Lastly, clinicians felt
that a cardiac stress test was not required for minimum car-
diac workup for patients in general.
This study has several strengths. It was open to all consul-
tant renal clinicians in the United Kingdom, and all renal
units were contacted to encourage participation. A signifi-
cant number of clinicians replied in round 1, and there was
minimal dropout in round 2. As well as collecting ratings of
agreement, participants were also able to write comments
in the free-text boxes provided. These boxes captured data
that helped to explain variation in some responses but also
to improve the questionnaire for round 2. The content of
the Delphi was informed by a recent national survey of all
UK renal units and therefore asked about current issues that
were relevant to all UK renal clinicians. The Delphi approach
also enabled participants to contribute and to receive group
feedbackwhile remaining anonymous to one another. ADelphi
approach has been used in many other settings, including for
selecting healthcare quality indicators13 and outcome measures
in clinical studies.14
There are also limitations to the study and points to con-
sider. The proportion of clinicians recruited in the United
Kingdom was moderate (25% of nephrologists and 16% of
surgeons), although the study did capture data from 69%
of renal units, and included a reasonable mix of nephrolo-
gists and surgeons from both transplant and nontransplant
units. The study was part of a national research program in-
volving all renal units in the United Kingdom, and this may
have led the clinicians with links to the project to be more
likely to respond. These points may have relevance to the
generalizability of the findings, as the participants may be
from research-active renal units and have greater knowledge
of the study. In addition, it should be noted that clinicians
were asked to base their answers on “an ideal world” rather
than what was feasible for their renal unit, which is usual in
Delphi studies but has implications for the applicability of
the findings in practice. The stakeholder meeting was oppor-
tunistic but enabled us to engagewith amixed audience of se-
nior surgeons and nephrologists, as well as a wider group
interested in kidney transplantation, importantly including
patient representatives. However, due to the need to ensure
confidentiality, it was not feasible to exclude patients' re-
sponses from voting.
Those statements that reached consensus in the present
study can be compared with current recommendations and
may help inform future guidelines. New topics where clini-
cians were in agreement included the need for patient compli-
ance with treatment, and use of multidisciplinary clinical
teams in decision making. Within the survey, patient compli-
ance was not explicitly defined and therefore clinicians made
their own judgment about what constitutes evidence of “poor”
compliance. However, agreement on the statement indicated
that clinicians felt this was an important factor to consider. This
is supported byworldwide data where although clinicians re-
port that perceived compliance influences their decisionmak-
ing, they also recognize that it is difficult to define and may
not be predictive of future behavior.5 If considered for guide-
lines, further thought is required as to how clinicians would
assess compliance to avoid discriminating against patients
and making them aware of the requirements to adhere to
medication after transplantation.
Those statements on which there was consensus dis-
agreement in the Delphi process included limits for BMI
and age. Clinicians stressed that considering 1 factor in
isolation was unhelpful. When statements relating to BMI
and age cutoff approached consensus agreement, feedback
from clinicians suggested that these should only be approxi-
mate guidelines. Clinicians felt that a BMI limit of 40 kg/m2
could be a guideline for listing, although this limit was higher
than reported in existing guidelines where a BMI over
35 kg/m2 is considered a contraindication.15,16 Other guide-
lines and publications state that age alone should not be a
contraindication.15,17
Although consensus was achieved for some statements,
others indicated significant variation in clinicians' views.
The diversity in views is likely to reflect variation between
units in their approaches to listing and is also reflective of
the scarcity of evidence in some areas.18 Further research is
needed before recommendations can be incorporated into
guidelines. For example, clinicians need to know the impact
of BMI on patient outcomes after transplant and the cost-
effectiveness of different cardiac work-up pathways.
In summary, this study adds to available data on individ-
ual clinicians' views on factors influencing kidney transplant
listing decisions and identifies areas of consensus. The find-
ings can be used to inform the content of guidelines where
consensus was achieved and, by highlighting topic areas with
noticeable variation, indicate areas where further research
and policy development are needed. The findings also reflect
the uncertainty surrounding the absolute and relative risks of
events that may preclude listing, such as cardiac events that
are relevant to the BMI and CAD statements. There is a pau-
city of adequate contemporary observational data for these
issues and even as higher-grade studies are considered, there
remains a role for registry-based observational work that will
help define the absolute risks and thus guide more powerful
randomized clinical studies in this area.
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